_id
69172a1a3c536f8df2316d76
Ticker
VOR
Name
Vor Biopharma Inc
Exchange
NASDAQ
Address
100 Cambridgepark Drive, Cambridge, MA, United States, 02140
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.vorbio.com
Description
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Last Close
12.13
Volume
435077
Current Price
12.51
Change
3.132728771640552
Last Updated
2025-12-05T13:31:24.811Z
Image
https://logo.clearbit.com/www.vorbio.com
Ipo Date
2021-02-05T00:00:00.000Z
Market Cap
182515568
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9835
Sentiment Sources
4
Rating
3
Target Price
50.3333
Strong Buy
0
Buy
0
Hold
5
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
28107000
Operating Income
-28107000
Interest Expense
-
Pretax Income
-812684000
Net Income
-812684000
Eps
-121.62661704326712
Dividends Per Share
-
Shares Outstanding
21910630
Income Tax Expense
-
EBITDA
-812682000
Operating Margin
-
Total Other Income Expense Net
-784577000
Cash
160462000
Short Term Investments
10000000
Receivables
-
Inventories
-
Total Current Assets
172486000
Property Plant Equipment
3314000
Total Assets
176237000
Payables
885000
Short Term Debt
252000
Long Term Debt
-
Total Liabilities
2401724000
Equity
-2225487000
Depreciation
2000
Change In Working Capital
5057000
Cash From Operations
-53662000
Capital Expenditures
244000
Cash From Investing
-244000
Cash From Financing
21549000
Net Change In Cash
-32525000
PE
-
PB
-0.037559978081202004
ROE
36.51713085720114
ROA
-461.1313174872473
FCF
-53906000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
28107000
Quarters > 0 > income Statement > operating Income
-28107000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-812684000
Quarters > 0 > income Statement > net Income
-812684000
Quarters > 0 > income Statement > eps
-121.62661704326712
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6681794
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-812682000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-784577000
Quarters > 0 > balance Sheet > cash
160462000
Quarters > 0 > balance Sheet > short Term Investments
10000000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
172486000
Quarters > 0 > balance Sheet > property Plant Equipment
3314000
Quarters > 0 > balance Sheet > total Assets
176237000
Quarters > 0 > balance Sheet > payables
885000
Quarters > 0 > balance Sheet > short Term Debt
252000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2401724000
Quarters > 0 > balance Sheet > equity
-2225487000
Quarters > 0 > cash Flow > net Income
-812684000
Quarters > 0 > cash Flow > depreciation
2000
Quarters > 0 > cash Flow > change In Working Capital
5057000
Quarters > 0 > cash Flow > cash From Operations
-53662000
Quarters > 0 > cash Flow > capital Expenditures
244000
Quarters > 0 > cash Flow > cash From Investing
-244000
Quarters > 0 > cash Flow > cash From Financing
21549000
Quarters > 0 > cash Flow > net Change In Cash
-32525000
Quarters > 0 > ratios > PE
-121.62661704326712
Quarters > 0 > ratios > PB
-0.037559978081202004
Quarters > 0 > ratios > ROE
36.51713085720114
Quarters > 0 > ratios > ROA
-461.1313174872473
Quarters > 0 > ratios > FCF
-53906000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
2100000
Quarters > 1 > income Statement > gross Profit
-2100000
Quarters > 1 > income Statement > operating Expenses
274284000
Quarters > 1 > income Statement > operating Income
-274284000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1573669000
Quarters > 1 > income Statement > net Income
-1573669000
Quarters > 1 > income Statement > eps
-251.24146413579982
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6263572
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-241513000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1299385000
Quarters > 1 > balance Sheet > cash
190574000
Quarters > 1 > balance Sheet > short Term Investments
9991000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
204927000
Quarters > 1 > balance Sheet > property Plant Equipment
24000
Quarters > 1 > balance Sheet > total Assets
205371000
Quarters > 1 > balance Sheet > payables
669000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1711071000
Quarters > 1 > balance Sheet > equity
-1505700000
Quarters > 1 > cash Flow > net Income
-1573669000
Quarters > 1 > cash Flow > depreciation
2100000
Quarters > 1 > cash Flow > change In Working Capital
4629000
Quarters > 1 > cash Flow > cash From Operations
-35184000
Quarters > 1 > cash Flow > capital Expenditures
152000
Quarters > 1 > cash Flow > cash From Investing
646000
Quarters > 1 > cash Flow > cash From Financing
175065000
Quarters > 1 > cash Flow > net Change In Cash
142940000
Quarters > 1 > ratios > PE
-251.24146413579982
Quarters > 1 > ratios > PB
-0.052040436820083684
Quarters > 1 > ratios > ROE
104.51411303712558
Quarters > 1 > ratios > ROA
-766.2566769407559
Quarters > 1 > ratios > FCF
-35336000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
825000
Quarters > 2 > income Statement > gross Profit
-825000
Quarters > 2 > income Statement > operating Expenses
33291000
Quarters > 2 > income Statement > operating Income
-33291000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-32486000
Quarters > 2 > income Statement > net Income
-32486000
Quarters > 2 > income Statement > eps
-5.2050829270684345
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6241207
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-32466000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
805000
Quarters > 2 > balance Sheet > cash
50047000
Quarters > 2 > balance Sheet > short Term Investments
9988000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
64847000
Quarters > 2 > balance Sheet > property Plant Equipment
39683000
Quarters > 2 > balance Sheet > total Assets
109312000
Quarters > 2 > balance Sheet > payables
3732000
Quarters > 2 > balance Sheet > short Term Debt
4266000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
43243000
Quarters > 2 > balance Sheet > equity
66069000
Quarters > 2 > cash Flow > net Income
-32486000
Quarters > 2 > cash Flow > depreciation
825000
Quarters > 2 > cash Flow > change In Working Capital
-2638000
Quarters > 2 > cash Flow > cash From Operations
-31066000
Quarters > 2 > cash Flow > capital Expenditures
231000
Quarters > 2 > cash Flow > cash From Investing
-230000
Quarters > 2 > cash Flow > cash From Financing
-606000
Quarters > 2 > cash Flow > net Change In Cash
-31902000
Quarters > 2 > ratios > PE
-5.2050829270684345
Quarters > 2 > ratios > PB
1.181756944557962
Quarters > 2 > ratios > ROE
-49.169807322647536
Quarters > 2 > ratios > ROA
-29.71860362997658
Quarters > 2 > ratios > FCF
-31297000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3686000
Quarters > 3 > income Statement > cost Of Revenue
865000
Quarters > 3 > income Statement > gross Profit
-865000
Quarters > 3 > income Statement > operating Expenses
30446000
Quarters > 3 > income Statement > operating Income
-31311000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-30712000
Quarters > 3 > income Statement > net Income
-30712000
Quarters > 3 > income Statement > eps
-8.94016852182732
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3435282
Quarters > 3 > income Statement > income Tax Expense
-899724
Quarters > 3 > income Statement > EBITDA
-29847000
Quarters > 3 > income Statement > operating Margin
-849.4574064026045
Quarters > 3 > income Statement > total Other Income Expense Net
599000
Quarters > 3 > balance Sheet > cash
81949000
Quarters > 3 > balance Sheet > short Term Investments
9977000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
96507000
Quarters > 3 > balance Sheet > property Plant Equipment
41588000
Quarters > 3 > balance Sheet > total Assets
142891000
Quarters > 3 > balance Sheet > payables
1505000
Quarters > 3 > balance Sheet > short Term Debt
4215000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
46227000
Quarters > 3 > balance Sheet > equity
96664000
Quarters > 3 > cash Flow > net Income
-30712000
Quarters > 3 > cash Flow > depreciation
865000
Quarters > 3 > cash Flow > change In Working Capital
2816000
Quarters > 3 > cash Flow > cash From Operations
-24063000
Quarters > 3 > cash Flow > capital Expenditures
72000
Quarters > 3 > cash Flow > cash From Investing
-72000
Quarters > 3 > cash Flow > cash From Financing
53286000
Quarters > 3 > cash Flow > net Change In Cash
29151000
Quarters > 3 > ratios > PE
-8.94016852182732
Quarters > 3 > ratios > PB
0.44458513841761155
Quarters > 3 > ratios > ROE
-31.771910949267568
Quarters > 3 > ratios > ROA
-21.49330608645751
Quarters > 3 > ratios > FCF
-24135000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.547748236570809
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3528000
Annuals > 0 > income Statement > gross Profit
-3528000
Annuals > 0 > income Statement > operating Expenses
121185000
Annuals > 0 > income Statement > operating Income
-121185000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-116914000
Annuals > 0 > income Statement > net Income
-116914000
Annuals > 0 > income Statement > eps
-34.0333049804936
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3435282
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-117657000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4271000
Annuals > 0 > balance Sheet > cash
81949000
Annuals > 0 > balance Sheet > short Term Investments
9977000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
96507000
Annuals > 0 > balance Sheet > property Plant Equipment
41588000
Annuals > 0 > balance Sheet > total Assets
142891000
Annuals > 0 > balance Sheet > payables
1505000
Annuals > 0 > balance Sheet > short Term Debt
4215000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
46227000
Annuals > 0 > balance Sheet > equity
96664000
Annuals > 0 > cash Flow > net Income
-116914000
Annuals > 0 > cash Flow > depreciation
3528000
Annuals > 0 > cash Flow > change In Working Capital
5000
Annuals > 0 > cash Flow > cash From Operations
-99660000
Annuals > 0 > cash Flow > capital Expenditures
229000
Annuals > 0 > cash Flow > cash From Investing
96857000
Annuals > 0 > cash Flow > cash From Financing
53392000
Annuals > 0 > cash Flow > net Change In Cash
50589000
Annuals > 0 > ratios > PE
-34.0333049804936
Annuals > 0 > ratios > PB
0.2960347084747166
Annuals > 0 > ratios > ROE
-120.94885376148308
Annuals > 0 > ratios > ROA
-81.82040856317053
Annuals > 0 > ratios > FCF
-99889000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3492000
Annuals > 1 > income Statement > gross Profit
-3492000
Annuals > 1 > income Statement > operating Expenses
122544000
Annuals > 1 > income Statement > operating Income
-126036000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-117863000
Annuals > 1 > income Statement > net Income
-117863000
Annuals > 1 > income Statement > eps
-35.082460734153095
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3359599
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-114371000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
8173000
Annuals > 1 > balance Sheet > cash
31360000
Annuals > 1 > balance Sheet > short Term Investments
105815000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
140803000
Annuals > 1 > balance Sheet > property Plant Equipment
50098000
Annuals > 1 > balance Sheet > total Assets
209828000
Annuals > 1 > balance Sheet > payables
815000
Annuals > 1 > balance Sheet > short Term Debt
3830000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
59104000
Annuals > 1 > balance Sheet > equity
150724000
Annuals > 1 > cash Flow > net Income
-117863000
Annuals > 1 > cash Flow > depreciation
3492000
Annuals > 1 > cash Flow > change In Working Capital
650000
Annuals > 1 > cash Flow > cash From Operations
-100292000
Annuals > 1 > cash Flow > capital Expenditures
1069000
Annuals > 1 > cash Flow > cash From Investing
71008000
Annuals > 1 > cash Flow > cash From Financing
2938000
Annuals > 1 > cash Flow > net Change In Cash
-26346000
Annuals > 1 > ratios > PE
-35.082460734153095
Annuals > 1 > ratios > PB
0.1856735468140442
Annuals > 1 > ratios > ROE
-78.1978981449537
Annuals > 1 > ratios > ROA
-56.17124501973044
Annuals > 1 > ratios > FCF
-101361000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
8960000
Annuals > 2 > income Statement > gross Profit
-8960000
Annuals > 2 > income Statement > operating Expenses
84458000
Annuals > 2 > income Statement > operating Income
-93418000
Annuals > 2 > income Statement > interest Expense
1324000
Annuals > 2 > income Statement > pretax Income
-92094000
Annuals > 2 > income Statement > net Income
-92094000
Annuals > 2 > income Statement > eps
-46.56925086381222
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1977571
Annuals > 2 > income Statement > income Tax Expense
-1324000
Annuals > 2 > income Statement > EBITDA
-83134000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1324000
Annuals > 2 > balance Sheet > cash
57706000
Annuals > 2 > balance Sheet > short Term Investments
172539000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
236950000
Annuals > 2 > balance Sheet > property Plant Equipment
57078000
Annuals > 2 > balance Sheet > total Assets
299366000
Annuals > 2 > balance Sheet > payables
1772000
Annuals > 2 > balance Sheet > short Term Debt
3272000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
48759000
Annuals > 2 > balance Sheet > equity
250607000
Annuals > 2 > cash Flow > net Income
-92094000
Annuals > 2 > cash Flow > depreciation
2525000
Annuals > 2 > cash Flow > change In Working Capital
-12693000
Annuals > 2 > cash Flow > cash From Operations
-85144000
Annuals > 2 > cash Flow > capital Expenditures
8462000
Annuals > 2 > cash Flow > cash From Investing
-94091000
Annuals > 2 > cash Flow > cash From Financing
117140000
Annuals > 2 > cash Flow > net Change In Cash
-62095000
Annuals > 2 > ratios > PE
-46.56925086381222
Annuals > 2 > ratios > PB
0.06573306583614984
Annuals > 2 > ratios > ROE
-36.74837494563201
Annuals > 2 > ratios > ROA
-30.763012499749472
Annuals > 2 > ratios > FCF
-93606000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4451000
Annuals > 3 > income Statement > gross Profit
-4451000
Annuals > 3 > income Statement > operating Expenses
69018000
Annuals > 3 > income Statement > operating Income
-69018000
Annuals > 3 > income Statement > interest Expense
1553000
Annuals > 3 > income Statement > pretax Income
-68899000
Annuals > 3 > income Statement > net Income
-68899000
Annuals > 3 > income Statement > eps
-37.067643243772515
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1858737
Annuals > 3 > income Statement > income Tax Expense
-119000
Annuals > 3 > income Statement > EBITDA
-67584000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
119000
Annuals > 3 > balance Sheet > cash
119801000
Annuals > 3 > balance Sheet > short Term Investments
87668000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
214399000
Annuals > 3 > balance Sheet > property Plant Equipment
22523000
Annuals > 3 > balance Sheet > total Assets
242590000
Annuals > 3 > balance Sheet > payables
1545000
Annuals > 3 > balance Sheet > short Term Debt
1839000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
26327000
Annuals > 3 > balance Sheet > equity
216263000
Annuals > 3 > cash Flow > net Income
-68899000
Annuals > 3 > cash Flow > depreciation
1434000
Annuals > 3 > cash Flow > change In Working Capital
-9185000
Annuals > 3 > cash Flow > cash From Operations
-69144000
Annuals > 3 > cash Flow > capital Expenditures
3894000
Annuals > 3 > cash Flow > cash From Investing
-91651000
Annuals > 3 > cash Flow > cash From Financing
232911000
Annuals > 3 > cash Flow > net Change In Cash
72116000
Annuals > 3 > ratios > PE
-37.067643243772515
Annuals > 3 > ratios > PB
0.07159467504843639
Annuals > 3 > ratios > ROE
-31.85889403180387
Annuals > 3 > ratios > ROA
-28.4014180304217
Annuals > 3 > ratios > FCF
-73038000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-121.62661704326712
Valuation > metrics > PB
-0.037559978081202004
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
36.51713085720114
Profitability > metrics > ROA
-471.15939844393165
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-14053.5
Risk > final Score
-56184
Risk > verdict
High
Liquidity > metrics > Current Ratio
151.70272647317503
Liquidity > metrics > Quick Ratio
151.70272647317503
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
80
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
29
Prev Risks > 1
-6610
Prev Risks > 2
-85
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:23:46.227Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-121.63
Earnings History > 0 > eps Estimate
-0.104
Earnings History > 0 > eps Difference
-121.526
Earnings History > 0 > surprise Percent
-116851.9231
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-251.24
Earnings History > 1 > eps Estimate
-0.2243
Earnings History > 1 > eps Difference
-251.0157
Earnings History > 1 > surprise Percent
-111910.7
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.26
Earnings History > 2 > eps Estimate
-0.208
Earnings History > 2 > eps Difference
-0.052
Earnings History > 2 > surprise Percent
-25
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-18
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.44
Earnings History > 3 > eps Estimate
-0.3067
Earnings History > 3 > eps Difference
-0.1333
Earnings History > 3 > surprise Percent
-43.4627
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4
Earnings History > 4 > eps Estimate
-0.4
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.41
Earnings History > 5 > eps Estimate
-0.42
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
2.381
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.45
Earnings History > 6 > eps Estimate
-0.38
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-18.4211
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.39
Earnings History > 7 > eps Estimate
-0.5
Earnings History > 7 > eps Difference
0.11
Earnings History > 7 > surprise Percent
22
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.49
Earnings History > 8 > eps Estimate
-0.47
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-4.2553
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.45
Earnings History > 9 > eps Estimate
-0.43
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-4.6512
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.43
Earnings History > 10 > eps Estimate
-0.38
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-13.1579
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.52
Earnings History > 11 > eps Estimate
-0.6
Earnings History > 11 > eps Difference
0.08
Earnings History > 11 > surprise Percent
13.3333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.63
Earnings History > 12 > eps Estimate
-0.61
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-3.2787
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.58
Earnings History > 13 > eps Estimate
-0.66
Earnings History > 13 > eps Difference
0.08
Earnings History > 13 > surprise Percent
12.1212
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.61
Earnings History > 14 > eps Estimate
-0.51
Earnings History > 14 > eps Difference
-0.1
Earnings History > 14 > surprise Percent
-19.6078
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-14
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.48
Earnings History > 15 > eps Estimate
-0.57
Earnings History > 15 > eps Difference
0.09
Earnings History > 15 > surprise Percent
15.7895
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.5
Earnings History > 16 > eps Estimate
-0.62
Earnings History > 16 > eps Difference
0.12
Earnings History > 16 > surprise Percent
19.3548
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-09
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.5
Earnings History > 17 > eps Estimate
-0.5
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.67
Earnings History > 18 > eps Estimate
-0.62
Earnings History > 18 > eps Difference
-0.05
Earnings History > 18 > surprise Percent
-8.0645
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-217.49
Earnings History > 19 > eps Estimate
-4.4
Earnings History > 19 > eps Difference
-213.09
Earnings History > 19 > surprise Percent
-4842.9545
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-18
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-7.26
Earnings History > 20 > eps Estimate
-5.33
Earnings History > 20 > eps Difference
-1.93
Earnings History > 20 > surprise Percent
-36.2101
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-4.6734
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-4.6734
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-4.1354
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-4.1354
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-4.1354
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-4.1354
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-09-30
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-2.6196
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-2.6196
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.328
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-1.328
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.328
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-1.328
Earnings History > 26 > surprise Percent
-
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AVor Biopharma (VOR) Stock Jumps Over 30% After JPMorgan Upgrade: What December 2025’s Rally Really Means for Investors ts2.tech
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$50.3333
Analyst Picks
Strong Buy
0
Buy
0
Hold
5
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 48.15% of the total shares of Vor Biopharma Inc
1.
RA Capital Management, LLC(31.2954%)
since
2025/06/30
2.
5AM Venture Management, LLC(5.0218%)
since
2025/06/30
3.
FMR Inc(1.6519%)
since
2025/06/30
4.
Vanguard Group Inc(1.5121%)
since
2025/06/30
5.
UBS Group AG(1.209%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(1.0702%)
since
2025/07/31
7.
Johnson & Johnson(0.8483%)
since
2025/06/30
8.
Fidelity VIP Growth Initial(0.4881%)
since
2025/07/31
9.
Jane Street Group LLC(0.4149%)
since
2025/06/30
10.
Sarissa Capital Management LP(0.401%)
since
2025/06/30
11.
HRT FINANCIAL LLC(0.3746%)
since
2025/06/30
12.
Fidelity Advisor Equity Growth I(0.3743%)
since
2025/07/31
13.
Renaissance Technologies Corp(0.3695%)
since
2025/06/30
14.
Geode Capital Management, LLC(0.3438%)
since
2025/06/30
15.
Scientech Research LLC(0.3188%)
since
2025/06/30
16.
Vanguard Institutional Extnd Mkt Idx Tr(0.3166%)
since
2025/07/31
17.
BlackRock Inc(0.2958%)
since
2025/06/30
18.
Virtu Financial LLC(0.2178%)
since
2025/06/30
19.
Fidelity Growth Discovery(0.1932%)
since
2025/07/31
20.
Fidelity Extended Market Index(0.1661%)
since
2025/07/31
21.
Goldman Sachs Group Inc(0.1427%)
since
2025/06/30
22.
Two Sigma Investments LLC(0.1339%)
since
2025/06/30
23.
Galileo - Biotech Innovation Fund S USD(0.1281%)
since
2025/02/28
24.
Goldman Sachs Absolute Ret Trckr Instl(0.1175%)
since
2025/06/30
25.
State Street Corp(0.0915%)
since
2025/06/30
26.
TWO SIGMA SECURITIES, LLC(0.0745%)
since
2025/06/30
27.
Trustees Of Columbia University In The City Of New York(0.0726%)
since
2025/06/30
28.
Citigroup Inc(0.0691%)
since
2025/06/30
29.
Fidelity Total Market Index(0.0607%)
since
2025/07/31
30.
Fidelity Nasdaq Composite Index(0.0539%)
since
2025/07/31
31.
Pacific Select Large-Cap Growth I(0.0506%)
since
2025/08/31
32.
Extended Equity Market Fund K(0.0442%)
since
2025/06/30
33.
Fidelity Series Total Market Index(0.0411%)
since
2025/07/31
34.
Fidelity Advisor Series Equity Gr(0.0346%)
since
2025/07/31
35.
Spartan Extended Market Index Pool F(0.0336%)
since
2025/07/31
36.
NT Ext Equity Mkt Idx Fd - L(0.0284%)
since
2025/06/30
37.
Northern Trust Extended Eq Market Idx(0.0284%)
since
2025/06/30
38.
NT Ext Equity Mkt Idx Fd - NL(0.0237%)
since
2025/06/30
39.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0215%)
since
2024/12/31
40.
Spartan Total Market Index Pool G(0.0205%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-121.63
EPS Estimate
-0.104
EPS Difference
-121.526
Surprise Percent
-116851.9231%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.